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Abstract
Background:  Mammary Paget's disease and extramammary Paget's disease are neoplastic
conditions, in which there is intraepithelial (usually intraepidermal) infiltration by neoplastic cells
showing glandular differentiation. Mammary Paget's disease occurs exclusively on the nipple/areola
complex from where it may spread to the surrounding skin.
Case presentation: We here describe a case of Paget's disease occurring on the thoracic wall
site of a previous simple mastectomy, and also briefly summarise the most important aspects
leading to a diagnosis of mammary Paget's disease.
Conclusion: To the best of our knowledge, this is the first reported case of mammary Paget's
disease occurring after mastectomy. The absence of the nipple/areola complex obviously raised
some questions concerning whether it was mammary or extra-mammary Paget's disease, and how
it could occur in the absence of the nipple/areola complex.
Background
Mammary Paget's disease occurs exclusively on the nip-
ple/areola complex from where it may spread on to sur-
rounding skin. Extramammary Paget's disease occurs
most commonly in the anogenital region but can arise in
any area of skin and mucosa.
Mammary Paget's disease accounts for 2–3% of neoplastic
conditions of the breast and in most cases (82–92% in
several studies) tumour cells have spread to the skin of the
nipple and areola from underlying invasive carcinoma or
ductal carcinoma in situ [1-3]. The neoplasm associated
with mammary Paget's disease, which may or may not be
palpable, is usually centrally located (within 2 cm of the
areola) but occasionally may be more peripherally sited
[1,2]. In cases where a mass is palpable, invasive carci-
noma is likely to be found. Conversely, cases of mammary
Paget's disease with no palpable mass are more likely to
have ductal carcinoma in situ only (66% of cases in one
study) [2].
Mammary Paget's disease has been reported in the male
breast with no evidence that the disease behaves differ-
ently, although the numbers of cases reported are small
[4].
This paper describes a case of Paget's disease occurred on
the thoracic wall where simple mastectomy was per-
formed many years before.
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Case presentation
A 57-year-old woman underwent simple mastectomy
(according to Madden procedure) and axillary dissection
on 7 December 1995. She reported the appearance of
eczema of the nipple-areola complex some years before,
and the presence of a palpable mass for about two
months; no mention was made of nipple discharge or
ulceration. Histological examination revealed unifocal
Paget's disease of the nipple underlying an invasive muci-
nous ductal breast carcinoma (pT2 2.2 cm) with focal
aspects of intraductal carcinoma; none of the 21 nodes
obtained upon axillary dissection were involved in the
disease. Immunohistochemically, the tumour presented
high estrogen and low progesterone receptor positivity,
and a low-intermediate proliferative rate (Ki67 14%). No
secondary lung, liver or bone lesions were detected. On
the basis of the disease stage and histology, and age at
diagnosis, adjuvant hormonal treatment with tamoxifen
was started on 9 January 1996.
In February 1999, the patient complained of a 1 × 1.5 cm
hyperpigmented eczematoid erythematous area at the site
of ths previous mastectomy, whose size remained
unchanged for four years.
The beginning of its slow growth in 2003 led to a derma-
tological evaluation being advised, but this was delayed
by the patient until December 2004, when a biopsy was
performed. No scraping was possible as there was no
crusted lesion (Figure 1). Histological examination
showed Page's disease (immunohistochemistry: ER
30%+, PgR 5%+, Ki67 19%+, c-erbB2 positive, CEA and
EMA positive; cytokeratin 20 and 5 negative, cytokeratine
7 and 8/18/19 positive; S100 negative). Unfortunately,
the patient did not visit our clinic until three months after
the diagnosis and so, on the basis of the histological diag-
nosis, the area was surgically resected on 22 March 2005.
Histological examination confirmed the lesion to be
Paget's disease of the thoracic skin; the surgical margins
were negative (Figure 2). A new hormonal therapy with
letrozole was subsequently started.
Clinical aspects of mammary Paget's disease occurred on the thoracic wall where simple mastectomy was performed some  years before Figure 1
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Discussion
To the best of our knowledge, this is the first reported case
of mammary Paget's disease occurring after mastectomy.
The absence of the nipple/areola complex obviously
raised some questions concerning whether it was mam-
mary or extra-mammary Paget's disease, and how it could
occur in the absence of the nipple/areola complex.
The first question was answered by the immunohisto-
chemical examination because hormonal receptors can
only be detected in mammary Paget's disease. The second
one could be explained by the high prevalence of multifo-
cal disease in patients with Paget's mammary disease.
However in this case the pathologist revealed unifocal
Paget's disease of the nipple underlying an invasive muci-
nous ductal breast carcinoma with focal aspects of intra-
ductal carcinoma and surgical negative margins in the
histological specimen in 1995 when mastectomy was per-
formed and unifocal Paget's disease of the thoracic skin
with no microinvasion and negative margins at the time
of the second resection.
In order to understand this better, we here briefly summa-
rise the most important aspects leading to the diagnosis of
mammary Paget's disease, which was first described by
James Paget in 1874 [5] as a neoplastic condition that
exclusively affects the nipple/areola complex from where
it may spread to the surrounding skin. It is clinically char-
acterised by a demarcated, thickened, eczematoid ery-
thematous weeping or crusted lesion with irregular
Histological examination of Page's disease: Paget's cells, with abundant pale cytoplasmand pleomorphic nuclei, replace the basal  epidermis and are scattered individually throughout the squamous epithelium Figure 2
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borders; nipple discharge and ulceration may sometimes
occur, and there may be an associated palpable breast
tumour. Some cases of mammary Paget's disease are clin-
ically occult and only detected histologically when a rep-
resentative section of the nipple and areola is submitted
from a mastectomy. The differential clinical diagnoses
include generalised inflammatory skin conditions such as
eczema and psoriasis, as well as erosive adenomatosis, a
condition that is specific to the nipple.
Mammary Paget's disease accounts for 2–3% of all neo-
plastic conditions of the breast and, in most cases (up to
90%), microscopic examination shows intraepithelial
(usually intraepidermal) infiltration by neoplastic cells
with glandular differentiation. Most cases originate from
in situ or invasive ductal carcinoma in the underlying
breast tissue [1-3], but rare cases appear to have originated
primarily within the nipple epidermis. The neoplasm
associated with mammary Paget's disease is usually
located centrally (within 2 cm of the areola) but may occa-
sionally may be more peripheral [1,5].
When a mass is palpable, invasive carcinoma is likely to
be found, which is said to be more commonly multifocal
with axillary node involvement, and to lead to worse sur-
vival than in patients whose tumour does not show an
epidermal spread [2]. However, other studies comparing
invasive carcinoma patients with and without mammary
Paget's disease have found that the most important prog-
nostic factor is the presence or absence of axillary metas-
tases, rather than the presence of skin involvement [6].
Conversely, patients with mammary Paget's disease and
no palpable mass are more likely to have in situ ductal car-
cinoma only [2]. The breast cancer associated with mam-
mary Paget's disease is often multifocal.
The surgical management of mammary Paget's disease
associated with neoplastic disease consists of mastectomy,
which is frequent in such patients because of the high
prevalence of multifocal disease; breast-conserving sur-
gery, which in these cases consists of a wide local excision
of the tumour with the excision of the nipple/areola com-
plex, is regarded as being more appropriate to an underly-
ing unifocal breast tumour. Conservative surgery with
adjuvant radiotherapy may be possible in selected cases
[7,8], although radiotherapy alone has been proposed as
a viable alternative to surgery for the rare cases that lack
any signs of associated neoplastic disease in the underly-
ing breast tissue [8-10].
The presence of an associated invasive tumour obviously
drives the therapeutic decision-making process. Immuno-
histochemistry can be very helpful in diagnosing mam-
mary Paget's disease, particularly in cases like ours with an
unusual clinical appearance, because pathologists can
make some immunohistochemical analysis using particu-
lar markers, some of which are quite sensitive or specific.
Among the cytokeratins, cytokeratin 7 and 20 are sensitive
but not specific markers of mammary Paget's disease, and
most cases are labelled by EMA antibody. Only approxi-
mately 35% of the cases of mammary Paget's disease show
anti-CEA antibodies. The tumour cells in mammary
Paget's disease generally have a similar immunohisto-
chemical steroid receptor profile to that of the associated
breast carcinoma; c-erbB2 is detected in most cases of
mammary Paget's disease (90–100%) and in the associ-
ated breast tumour in about 44% of cases of in situ ductal
carcinoma, and is more commonly present in high-grade
(comedo and micropapillary) lesions. S100 is useful in
differentiating Paget's disease from melanoma, but may
be expressed in up to 25% of cases of mammary Paget's
disease (a similar frequency to that observed in mammary
carcinoma) [11].
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